The Positively Quit Trial for Smoking Cessation
This study is testing two programs, "Positively Me" and "Positively Living," to help people quit smoking. Both programs are designed for individuals with certain health conditions and involve 12 group sessions delivered online. The main goal is to see if "Positively Me," which focuses on quitting smoking, works better than "Positively Living," which is a general healthy living program, at helping people stop smoking. All participants will receive advice to quit and an offer of nicotine replacement therapy (NRT) patches. To join, you must be at least 18 years old, smoke cigarettes, test positive for cotinine (a marker of nicotine use), be motivated to quit, and have a smartphone, laptop, or tablet with internet access for online group sessions. The study will measure if you successfully quit smoking after one year.
- Study design
- This is an interventional study comparing two behavioral programs. It plans to enroll 482 participants.
- What's involved
- You would participate in 12 online group sessions. Your smoking status will be checked at 360 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your smoking status will be checked at 360 days after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Positively Quit Trial for Smoking Cessation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephanie L Marhefka, PhD · PRINCIPAL_INVESTIGATOR · University of South Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Biochemically confirmed 7-day point prevalence abstinence (BC7ppa) day 360study day 360
Participant is asked if she has smoked a cigarette, even a puff, in the past 7 days. If she reports abstinence, she also completes a cotinine swab test over video-conferencing to determining cotinine levels. Levels less than 10ng/ml will be considered abstinence. BC7ppa will be coded as abstinence-indicating if she answers "no" to the question and cotinine levels suggest abstinence.
- Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) day 360study day 360
Participant is asked if she has smoked a cigarette, even a puff, in the past 30 days. If she reports abstinence, she also completes a cotinine swab test over video-conferencing to determining cotinine levels. Levels less than 10ng/ml will be considered abstinence. BC30ppa will be coded as abstinence-indicating if she answers "no" to the question and cotinine levels suggest abstinence.
- Biochemically confirmed sustained abstinence (BC.SA) day 360Study day 360
At day 42 (2 weeks post-quit day; provides a grace period), participant is asked the BC7ppa question (see outcome 1). Then, at each full and brief assessment going forward, beginning at day 90, participant is asked if she has smoked a cigarette, even a puff, since the last assessment. If she reports abstinence, she also completes a cotinine swab test over video-conferencing to determining cotinine levels. Levels less than 10ng/ml will be considered abstinence. BC.SA will be coded as abstinence-indicating if she answers "no" to the sustained abstinence question at each assessment and cotinine levels at each assessment suggest abstinence.